Malady Kyle sold DXCM
September 5, 2025 · Form 4 insider transaction
Malady Kyle sold 667 shares of DexCom, Inc. at $80.86 per share, a transaction worth $53.9K. The trade was recorded as open-market sale and disclosed on an SEC Form 4, filed 4 days after the transaction.
Direction
Disposed (sell-side)
Shares
667
Price
$80.86
Total value
$53.9K
InsiderMalady Kyle
Role—
CompanyDexCom, Inc. (DXCM)
SecurityCommon Stock
Transaction codeS: Open-market sale
Transaction dateSeptember 5, 2025
Filing dateSeptember 9, 2025
Shares owned after22,667
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
On June 6, 2025, Mr. Malady adopted a 10b5-1 Plan. This 10b5-1 Plan allows the orderly disposition of shares owned by Mr. Malady. The shares set forth above were sold pursuant to the 10b5-1 Plan.; Included in this number are 5,192 unvested restricted stock units which were granted on May 8, 2025 and shall vest on the earlier of the one year anniversary of the grant date or the date of DexCom, Inc.'s 2026 Annual Meeting of Stockholders.